Dr Mengyu Lu > Kirkland & Ellis > Hong Kong, Hong Kong > Lawyer Profile
Kirkland & Ellis Offices
26TH FLOOR, GLOUCESTER TOWER
THE LANDMARK, 15 QUEEN'S ROAD CENTRAL
HONG KONG
Hong Kong
- Firm Profile
- Go to...
Dr Mengyu Lu
Work Department
Corporate
Position
Partner
Career
Dr. Mengyu Lu is a partner in Kirkland’s Hong Kong office who leads the Asia capital markets practice. Dr. Lu has extensive experience in advising corporate clients in connection with its corporate structures, share incentive plans, corporate governance, capital markets transactions as well as post-listing compliance and M&As. Dr. Lu also works closely with the leading investment banks on capital markets and M&A transactions in the region. She is particularly well recognized in advising corporate clients in the “new economy” sectors, including healthcare, new consumer and TMT sectors. Over the years, Dr. Lu has advised over 100 corporate clients on their capital markets and M&A transactions. Her major corporate clients include, among others, Haidilao, NIO, Will Semiconductor, TUHU Car Inc. and Kelun Biotech.
Dr. Lu was recognized as a “Leading Lawyer” for China equity capital markets by Chambers Global and Chambers Greater China, and a “Highly Regarded” lawyer for Hong Kong capital markets by IFLR1000. IFLR named her to its list of 2021 “Asia Best Lawyers”, and Asian Legal Business named her to its 2021 Asia “40 under 40” list. She was also listed in China Business Law Journal’s “China’s Elite 100 Lawyers” in 2016–2018 and 2020–2021.
Languages
English, Mandarin, Cantonese
Education
Chinese Academy of Social Sciences, Ph.D., Economics
Duke University School of Law, LL.M.
China University of Political Science and Law, LL.B.
Lawyer Rankings
Hong Kong > Capital markets (equity)
(Leading individuals)With a strong team of New York and locally-qualified practitioners based in Hong Kong and also able to leverage significant resources on the mainland, Kirkland & Ellis is a popular choice among issuers and underwriters on Hong Kong listings and follow-on offerings, as well as US IPOs and Rule 144A and Regulation S offerings. SPAC-related work is a strength for the firm and in spite of economic headwinds dampening investor demand, the firm advised Vision Deal HK Acquisition Corp on one of the earliest and relatively rare SPAC IPOs following the liberalisation of the market. Team head David Zhang
had a key role on this matter and has also been active handling a number of de-SPAC mandates. Mengyu Lu, who has also been active handing SPAC transactions as well as efforts to fashion a regulatory framework in Hong Kong for the listings of SPACs and potential de-SPAC transactions, has a booming Hong Kong IPO practice, helping many Chinese companies, including within new economy sectors, to list.
Lawyer Rankings
Top Tier Firm Rankings
- Capital markets (equity)
- Corporate (including M&A)
- Investment funds
- Private equity
- Restructuring and insolvency